UAE doctor who went viral for brave stance during Covid returns after 20 years
The first thing Dr Ajlan Al Zaki noticed in his patients here in the UAE was an instilled fear of cancer. 'It's okay to say the C word. A lot of patients come in and they hear the word cancer and that brings in fear. There are concerns, and understandably so. They just want to make sure that they're okay. That sort of awareness needs to be spread out where cancer is not necessarily a bad word,' he told Khaleej Times.
Another thing he noticed in patients here was how everything was taken at face value. 'We tend to use Dr Google or AI,' Al Zaki said. 'I need to tell my patients don't believe everything you read online. Please don't do it. You can Google a little bit, but don't believe everything you read online.'
Dr Al Zaki, a triple board-certified haematologist and oncologist previously based out of the US, went viral during the beginning of the Covid pandemic in 2020 after the UAE government called on its citizens abroad to return home, but he decided not to leave and to stay in order to perform his duty as a doctor and treat infected patients.
Currently, he is director of Burjeel Haematology Oncology and Cellular Therapy Centre and a specialist in CAR-T cell and Advanced immunotherapies. 'The UAE has supported me during this whole time. I was going through my personal journey of developing experience and getting that experience where I felt like I would be comfortable enough to bring everything back,' Al Zaki said.
More affordable CAR-T cell therapy
Today, the haematologist-oncologist is continuing his path of helping cancer patients by reducing the costs of one of the most personalised and expensive cancer treatments–chimeric antigen receptor CAR-T cell therapy. This type of treatment involves genetically engineering a patient's T-cells and training them to recognise a specific marker on a cancer cell and then fighting those off once given back to the patient. Because this treatment is so personalised, the costs of treatment are significantly higher. One single infusion could cost a whopping $1 million.
During the first day of the Abu Dhabi Global Health Week event, which ran from April15-17, Burjeel Holdings announced its partnership with Caring Cross, a US-based non-profit, to reduce the costs of CAR T cell therapy treatment by up to 90% compared to international costs. 'It could be up to 90%, where that bar is going to be in the UAE, we don't know. But I know for sure that we can provide it at a lower cost than what's commercially approved,' Al Zaki said.
Al Zaki explained that the reason why costs may be reduced by that much is due to the technology offered by Caring Cross to locally manufacture the cells. 'When you're making the CAR-T cells, when you're programming the CAR-T cells, think of it as downloading software on your iPhone. So, you have your iPhone, which is your T cells, and you want to upgrade your iPhone, you have to download software,' he said.
Al Zaki continued: 'It's the software sometimes which can be really expensive. And so, what Caring Cross does is they make the software, and they provide it at a significantly reduced cost. And we use that software to then upgrade the T cells.'
'I want people to have access to these kinds of therapies anywhere in the world. That's why we went into medicine,' he said.
From engineering to medicine
After starting his academic journey as a chemical engineer, Al Zaki came across a professor who suggested that he tries to do some research. At the time, Al Zaki had plans to work for one of the oil companies in the UAE. However, that eye-opening conversation prompted him to switch course and turn to research as a career path. 'The idea of cancer always intrigued me at that time. How do we diagnose it? How do we treat it? What are new ways that we are using to prevent it from occurring in the beginning?' he said.
Six years and a PhD in research later, Al Zaki decided that medicine was his true calling and pursued medical school.
In 2012, when his grandfather was diagnosed with late-stage cancer, Al Zaki grew inspired to help people when they are at their worst, whether it be medical or emotional support. He said that despite the condition his grandfather was in, he knew how important it was to just be present. 'I read once that sometimes the best therapy that you can give to a patient that's not administered by way of mouth or way of the vein, is really through the way of the ear. Sometimes [words of comfort are] the strongest therapy you can give to someone.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Today
a day ago
- Gulf Today
New blood test detects early ovarian cancer
An experimental blood test detected early-stage ovarian cancer in patients with vague symptoms that would likely be misdiagnosed using currently available methods, researchers said in a new report. There are no reliable blood tests for these patients, and existing invasive tests often miss early-stage ovarian tumours, the researchers wrote in Cancer Research Communications. Using machine learning tools, the researchers identified multiple biomarkers - from across a wide range of molecules and processes in the body - that could be combined into a single test that detects all sub-types of the disease, at all stages. Tested at a large medical centre on blood samples from nearly 400 women with possible symptoms of ovarian cancer, the test was 92 percent accurate at identifying those with any stage of ovarian cancer and 88 percent accurate at identifying those with Stage I or Stage II disease, according to the report. Oriana Papin-Zoghbi, chief executive officer of the company developing the new test -Denver, Colorado-based AOA Dx - said the findings show its potential to aid 'in making faster, more informed decisions for women who need urgent clarity during a challenging diagnostic process.' Ovarian cancer is the fifth leading cause of cancer-related deaths among women, largely due to delays in diagnosis until after the disease has spread in the body, at which point it's harder to treat. More than 90 percent of patients with early-stage ovarian cancer experience symptoms that can be mistaken for benign conditions, such as bloating, abdominal pain, and digestive issues. WAM
Gulf Today
3 days ago
- Gulf Today
Aunt's heroic donation saves nephew as UAE doctors perform youngest infant liver transplant
A five-month old 4.4-kilogramme Emirati boy, stricken with a rare unpreventable recessive X disorder, and the youngest recipient of a donated liver in the UAE, courtesy of his 37-year-old paternal aunt, shall now be on lifelong monitoring and treatment. Fifth child Ahmed Al Yassi is recuperating at the Burjeel Medical City-Paediatric Intensive Care Unit (BMC-PICU) since his April 4, 2025 12-hour ultra-delicate transplantation. His giant strength, and his family's and the medical team's indefatigability, serve as an inspiring testimony for the August 13 'World Organ Donation Day." The WODD 2025 theme is 'Answering the Call,' for the continuous correct information dissemination on the necessity to grant one's organ/s to save lives. In the UAE, since 2017, is the Ministry of Health and Prevention-spearheaded National Programme for Donation and Transplantation of Human Organs and Tissues-Hayat Programme. According to a press statement, quoting undersecretary, Dr. Mohammed Salim Al Olama, it has been boosted with advanced digital solutions and artificial intelligence that guarantees transparency and efficiency at every stage of organ donation and transplantation process. Its website as of 4:30 p.m. of August 13 had '37,298 registered donors.' From a press statement quoting Department of Health-Abu Dhabi undersecretary Dr. Noura Khamis Al Ghaithi, 1,380 transplantations, through the Hayat Programme, were carried out from 2017 to 2024. The 2024 were at 290: seven heart, 142 kidney, 117 liver, 22 lung, and two pancreas. Over at BMC, elated was Ahmed's father Yahya: 'My baby's recovery is nothing short of a miracle. We were once a family living in fear of losing another child due to a liver problem. I hope our story inspires others to come forward, to learn more, and consider becoming donors. You never know whose life might change.' Abdominal Transplant and Hepato-Pancreatic Biliary surgeon Dr. Johns Shaji Mathew confirmed that Ahmed shall receive 'lifetime monitoring and therapy that includes immunosuppressive medications to prevent organ rejection, while the transplant on Ahmed has resolved the liver-related complications.' 'Ahmed will be regularly supervised by liver and genetics specialists for ongoing evaluation,' added Mathew, among the multi-disciplinary team members, led by Burjeel Abdominal Multi-Organ Transplant Programme-Transplant Surgery director Dr. Gourab Sen. The other on-case Transplant Team were Anaesthesia Division chairperson Dr. Ramamurthy Baskaran and specialists Dr. George Jacob and Dr. Anshu S., and Paediatric Intensive Care Unit (PICU) consultant Dr. Kesava Ramakrishnan. Their advice: 'urgent transplantation.' Ahmed's health debilitated due to the rise of his liver enzymes immediately birth. His diagnostics demonstrated that he is afflicted with ATP6AP1-Congenital Disorder of Glycosylation (ATP6AP1-CDG). Instrumental were the 'family's conviction' and the bravery-cum-volunteerism of mother-of-five Haifaa, Yahya's sister-in-law, who passed all compatibility tests. She and Ahmed are A+ blood type. Mathew said: 'The family's conviction came from the fact that without a transplant, Ahmed's survival chances were extremely low. They already experienced the loss of an older son to similar complications, which made them determined not to lose another.' 'The doctors gave us new hope. My sister-in-law gave us life again,' said Yahya. The USA-headquartered public-private-supported Frontiers in Congenital Disorders of Glycosylation (FCDG) portal notes that ATP6AP1-CDG generally affects males at one every one million. Ahmed has so far become the 31st survivor. There are 30 in other countries. The oldest patient is age 67. ATP6AP1-CDG 'age onset' range from the mother's pregnancy to age two, notes the Orphanet Knowledge on Rare Diseases and Orphan Drugs. From the FCDG, patients 'may have variable degree of liver dysfunction and immunodeficiency with recurrent infections.' Impaired-ness include developmental delays; abnormal body movement; gastrointestinal, urinary and genital problems; congenital heart defects and blood syndromes. So far, the solution is 'liver transplantation which has been successful in patients with severe liver failure.' Mathew said decreased transmission would only be via 'genetic screening and pre-marital genetic counselling to identify carriers and inform reproductive decisions for families with a known history.' Ahmed's family history has 'his grandfather passed on in 2010 due to a liver disease.' From the BMC Transplant Team that encourages a well-informed community on organ donation and transplantation: 'Ahmed's survival underscores the transformative power of organ donation and the advanced capabilities we now have in the UAE to perform complex, high-stakes surgeries for even the tiniest patients. Liver transplantation is not just surgical procedure; it is a second chance at life for those with no other options.'
The National
3 days ago
- The National
'Nothing short of a miracle': Baby Ahmed youngest in UAE to get liver transplant
A five-month-old Emirati boy has become the youngest in the country to receive a liver transplant after an aunt's lifesaving donation. Ahmed Yahya's liver was failing because of a rare genetic condition. As doctors appealed for a suitable living donor, time was running out for Ahmed until his 36-year-old aunt volunteered to help. Parents Yahya and Zainab Al Yassi had experienced tragedy before, when their first son succumbed to a similar condition. Ahmed's fight depended on the good fortune of finding a genetic match to ensure his 4.4kg body would not reject a donor organ. Now, to mark World Organ Donation Day on August 13, Ahmed's family and the doctors are talking about the operations that saved his life. 'I still remember the pain when we lost our first son to liver disease,' said Mr Al Yassi. 'When we heard our second son had a similar problem, I thought this was our destiny. But the doctors gave us new hope. And my sister-in-law, she gave us life again. My baby's recovery is nothing short of a miracle.' Unbreakable bond Ahmed's aunt, who had never considered becoming a donor, immersed herself in research and discussions with the transplant team. 'I read everything I could find,' she said. 'I realised that donating part of my liver could save his life, and I knew I had to do it. It's a bond that nothing in this world can break.' Doctors first raised concern when they recorded high liver enzymes shortly after Ahmed was born. Doctors at Burjeel Medical City (BMC) diagnosed him with an ATP6AP1-related congenital disorder of glycosylation, a disorder so rare there are fewer than 25 known cases worldwide. Ahmed's aunt – the wife of his father's brother – volunteered and discovered she was a perfect match. Doctors rushed both to surgery. Ahmed, and his brother, were named in honour of their grandfather, who died in 2010 from liver disease. As Ahmed was so young, the procedure proved to be one of the most technically challenging paediatric surgeries conducted in the Gulf region, said doctors who performed the surgery in April. 'This disease is a severe, multisystem condition that particularly affects the liver,' said Dr Johns Shaji Mathew, abdominal transplant and hepato pancreatico biliary surgeon at BMC. 'In Ahmed's case, the disorder was progressing rapidly towards liver failure. Given the rarity of the condition, there were no clear answers, only tough questions. Yet we had to act.' Rare condition Congenital disorders of glycosylation (CDG) affect the healthy function of cells. A chemical malfunction results in a number of serious health problems such as liver disease, abnormal bleeding, seizures and heart problems. Doctors prepared a graft from the donor to fit Ahmed. In total, the complex surgery took 12 hours. Despite the high-risk nature of the operation and the boy's fragile condition, the surgery was a success. Ahmed began feeding within days, and his liver function was excellent. He now belongs to about two dozen survivors through transplantation. 'In an infant this tiny, every structure is delicate beyond imagination, each vessel was thinner than a matchstick, and the margin for error was virtually zero,' said Dr Gourab Sen, director of transplant surgery at the Burjeel Abdominal Multi-Organ Transplant Programme. 'The surgery required not only technical expertise but constant focus, as we were working in millimetres, sometimes even fractions of a millimetre. 'It is not just a surgical procedure, it is micromillimetre craftsmanship performed under extreme pressure, with every member of the team synchronising perfectly to keep the child stable throughout.' Since the launch of Hayat – the National Programme for Donation and Transplantation of Human Organs and Tissue – in 2017, a total of 1,090 organ transplants have been performed across the Emirates until 2024, with 290 during the past year alone. The 2024 list included seven heart transplants, 142 kidney transplants, 117 liver transplants, 22 lung transplants, and two pancreas transplants. Inspirational story These achievements are made possible by four leading transplant centres, including Cleveland Clinic Abu Dhabi, Sheikh Khalifa Medical City (SKMC), Burjeel Medical City (BMC), and Sheikh Shakhbout Medical City (SSMC). Mr Al Yassi said he hoped his son's success may encourage more people to consider becoming organ donors. 'We were once a family living in fear of losing another child, but now we are celebrating a second chance at life,' he said. 'I hope our story inspires others to come forward, to learn more, and to consider becoming donors. You never know whose life you might change.'
